ANALISIS KADAR ACTH SETELAH PENGGUNAAN METILPREDNISOLON MEGADOSIS PADA PASIEN ANAK DENGAN LUPUS NEFRITIS (Penelitian dilakukan di SMF Ilmu Kesehatan Anak Divisi Nefrologi RSUD Dr. Soetomo Surabaya) by AGHNIA FUADATUL INAYAH, 051615153032
x 
 
ABSTRACT 
 
ANALYSIS OF ACTH LEVELS AFTER MEGADOSE METHYLPREDNISOLONE 
THERAPY IN PEDIATRIC PATIENTS WITH LUPUS NEPHRITIS  
(Study at Division of Nephrology, Pediatric Department,  
Dr. Soetomo Teaching Hospital Surabaya) 
 
Background : Recommendation for treatment of childhood lupus nephritis (LN) is a 
megadose methylprednisolone (MP) therapy which may cause suppressive effect on HPA 
axis. Megadose or pulse MP therapy is a therapy with prednisone-equivalent dosage of more 
250 mg per day (maximum dose of 1000 mg MP) for few days, usually no more than 5 days. 
Suppression in HPA axis is characterized by a decrease of ACTH level. This effect can 
decline cortisol levels and may affect metabolism phase, immune response and other balance 
function in the body. 
  
Objectives : To analyze ACTH levels after the use of megadose methylprednisolone in 
pediatric patients with lupus nephritis. 
 
Method : The prospective observational study was conducted at period from July to 
September 2018 and had been approved by Ethic Committee of Dr. Soetomo Teaching 
Hospital Surabaya. The patients who met inclusion criteria, namely patients aged < 18 years 
old diagnosed with lupus nephritis, and received megadose methylprednisolone therapy. 
Blood sampling were obtained at 06.00 to 10.00 a.m., then ACTH levels were measured 
before and after megadose methylprednisolone therapy using immunoassay method.  
 
Result : Seventeen patients were recruited  in this study consisted of 9 boys and 8 girls who 
were  6-18 years old. ACTH levels after the use of megadose methylprednisolone were 
decreased 31.8% from 22.6 ± 13.7 pg/mL to 15.4 ± 11.1 pg/mL (p <0.05). However, the 
decline of ACTH levels had been in the normal range. Blood pressure and blood sugar 
profiles were also within in  the normal range. Patients did not experience acute dehydration 
and weakness but nausea or vomiting appeared as much of 10% after the use of megadose 
methylprednisolone. In addition to 5% patient had developed full moon face. 
 
Conclusion : It could be concluded that ACTH levels were decreased after megadose 
methylprednisolone therapy, but suppression in HPA axis did not occur.  
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